Wells Fargo lowers Equifax target to $220, maintains Overweight
Wells Fargo analyst Jason Haas maintained an Overweight rating on Equifax but lowered the price target to $220 from $230. Meanwhile, UBS analyst Kevin McVeigh reiterated a Buy rating and increased the price target to $215 from $212, citing strong operational performance.
*this image is generated using AI for illustrative purposes only.
Wells Fargo analyst Jason Haas has maintained an Overweight rating on Equifax (NYSE: EFX) while lowering the price target to $220 from $230. The adjustment reflects a revised outlook on the stock's valuation despite the continued positive stance.
Separately, UBS analyst Kevin McVeigh has maintained a Buy rating on Equifax and raised the price target to $215 from $212. This revised target indicates confidence in the company's future growth prospects and strong operational performance.
Equifax operates as a data analytics and technology company, providing insights and solutions to businesses and consumers. The conflicting price target adjustments highlight differing views on the stock's near-term trajectory, though both firms recommend buying the shares.
The following table summarizes the recent rating and price target changes from both firms:
| Firm | Analyst | Rating | Previous Price Target | New Price Target |
|---|---|---|---|---|
| Wells Fargo | Jason Haas | Overweight | $230 | $220 |
| UBS | Kevin McVeigh | Buy | $212 | $215 |
Investors will be watching Equifax's upcoming earnings reports to see if the company meets the varied expectations set by these analysts.
What factors could drive Equifax's stock to converge towards the higher or lower end of the analyst price targets?
How might upcoming earnings reports influence the divergence in analyst opinions on Equifax's valuation?
What operational metrics will investors focus on to assess Equifax's growth prospects in the next quarter?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
